Symrise AG · XETR:SY1

Symrise — H1 2007 Earnings Presentation

14 slides from Symrise's earnings presentation, Aug 9, 2007

  1. Slide 1: Presentation H1 / 2007

    Slide 1: Presentation H1 / 2007

    Presentation H1 / 2007 August 9, 2007 1

  2. Slide 2: H1 / 07: We Deliver

    Slide 2: H1 / 07: We Deliver

    H1 / 07: WE DELIVER Fx adjusted sales growth in H1 / 07 at 6.8% (4.5% actual) EBITDA margin increased by 2.3 ppt from 19.5% to 21.8% Innovation awards for two Scent & Care “AND” products, strategic partnerships CUTECH and Brain/Analyticon start working Steng and Flavours Direct acquisitions qualifie

  3. Slide 3: We have worked on the AND portfolio in H1 / 07

    Slide 3: We have worked on the AND portfolio in H1 / 07

    WE HAVE WORKED ON THE „AND“ PORTFOLIO IN H1 / 07 > STENG acquisition adds to our strength in fast growing “convenience” segment and follows the trend to natural ingredients > Strategic partnership to develop innovative cosmetic products was signed (Cutech) > Beginning of April saw the beginning of t

  4. Slide 4: Core list positions drive growth with multinationals

    Slide 4: Core list positions drive growth with multinationals

    CORE LIST POSITIONS DRIVE GROWTH WITH MULTINATIONALS > Greater than proportional growth in S&C with big clients (+ 12%) > Proportional growth in F&N, stronger performance held up by slower than expected commercialization from North American customers > We experience increased briefing activities fro

  5. Slide 5: Emerging markets now account for close to 40% of sales

    Slide 5: Emerging markets now account for close to 40% of sales

    EMERGING MARKETS NOW ACCOUNT FOR CLOSE TO 40% OF SALES Sales split H1 / 07 > Relative weight of Emerging Countries increases and strategy works > Double digit growth in Emerging Markets vs. underlying growth of 6.8% for the Group > Strongest growth in Africa (>+ 15%), South America grows at 14% in H

  6. Slide 6: News

    Slide 6: News

    NEWS > Examples of prestigious Fine Fragrances wins: Lancome „Hypnose Homme“, Guerlain „L‘instant magic“, Victoria‘s Secret „Blossoming Romance“, Donna Karan „Be delicious“ line extensions > Star perfumer Jean-Claude Delville hired from top competitor for NY studio > Opening of regional sensory cons

  7. Slide 7: Financials

    Slide 7: Financials

    ”) _ < O zZ < Z LL.

  8. Slide 8: H1 / 07 – EBITDA margin improved to 21.8%

    Slide 8: H1 / 07 – EBITDA margin improved to 21.8%

    H1 / 07 – EBITDA MARGIN IMPROVED TO 21.8% 4.5% 400 300 > Fx adjusted growth of 6.8% (€m) Sales 200 632.3 660.9 > Growth rate (fx adjusted): 100 • F&N 6.1% 0 • S&C 7.5% H1 / 06 H1 / 07 16.4% 80 > EBITDA + € 20.3m yoy 60 EBITDA 1 > EBITDA grows even stronger than top (€m) 40 123.5 143.8 line at 16.4%

  9. Slide 9: H1 / 07 – Balance sheet / cash flow

    Slide 9: H1 / 07 – Balance sheet / cash flow

    H1 / 07 – BALANCE SHEET / CASH FLOW • Equity ratio at 33% (30.5% year end 06) • Working Capital development as expected, seasonality driven by product mix and raw material availability of natural products • Significant reduction of interest expense (from € -45m to €-19m) • € 33m Income tax expenses

  10. Slide 10: Q2 / 07 - Overview

    Slide 10: Q2 / 07 - Overview

    Q2 / 07 - OVERVIEW 3.7% 400 300 > Fx adjusted growth of 4.8% (€m) Sales 200 317.9 329.7 > Confirms our outlook 100 0 Q2 / 06 Q2 / 07 12.7% 80 60 > EBITDA + € 7.9m yoy EBITDA 1 (€m) 40 62.4 > EBITDA grows stronger than top line at 70.3 12.7% 20 0 Q2 / 06 Q2 / 07 t > EBITDA margin + 1.7 ppt in Q2 / 07

  11. Slide 11: Sales and margin growth in both divisions and above peers

    Slide 11: Sales and margin growth in both divisions and above peers

    SALES AND MARGIN GROWTH IN BOTH DIVISIONS AND ABOVE PEERS Recent sales growth outperformance 1 Sales growth by Division 1 H1 / 07 y-o-y sales growth (%) 7.5% 6.1% 6.8 % app. 4.7% F&N S&C Symrise Tier 1 group (average) 2 EBITDA margin development by Division H1 / 07 y-o-y EBITDA margin (%) t 0.5 pp 2

  12. Slide 12: Outlook

    Slide 12: Outlook

    OUTLOOK 12

  13. Slide 13: Outlook

    Slide 13: Outlook

    OUTLOOK > H1 / 07 figures support our full year target of 5-6% sales growth and >10% EBITDA growth > We expect a strong and growing EBITDA margin above 20% for 2007 > F&N is fully on track, Emerging Markets compensate delays in North America > S&C expects overall robust growth > Promising new busine

  14. Slide 14: Q&A

    Slide 14: Q&A

    Q&A Q&A ALWAYS INSPIRING 14 MORE …

Source: Internet Archive copy of investor.symrise.com

More decks from Symrise AG

All 71 Symrise decks